Nurse Practitioner · Gastonia, NC
NPI
1538504451
Since 2013
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1021 X Ray Dr
Gastonia, NC, 28054
Phone (704) 867-2341
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
985 services
Medicare patients, 2024
120
Average age 77
Drug cost, 2024
$824K
6,301 prescriptions
Company payments, 2025
$1,599
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by April M Mahrle-Henson was code 99214 (office e&m - established), 357 times for 114 patients. In total April M Mahrle-Henson billed 985 services in 34 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 357 | 114 | $66.34 | $24K |
| 81002 Clinical Chemistry | Office | 142 | 85 | $3.41 | $484 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 85 | 85 | $14.88 | $1,265 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 77 | 77 | $102.95 | $7,927 |
| 96372 Injection Administration | Office | 61 | 11 | $8.15 | $497 |
| 82044 Clinical Chemistry | Office | 35 | 32 | $6.11 | $214 |
| 99213 Office E&M - Established | Office | 25 | 19 | $44.60 | $1,115 |
| 99215 Office E&M - Established | Office | 21 | 16 | $104.19 | $2,188 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 19 | 19 | $14.85 | $282 |
| 87804 Immunoassay | Office | 19 | 13 | $15.37 | $292 |
| 82270 Immunoassay | Office | 14 | 14 | $4.29 | $60.06 |
| 99443 Telephone Services | Office | 12 | 11 | $40.24 | $483 |
By year: 2022 $63K for 1,414 services; 2023 $52K for 1,132 services; 2024 $43K for 985 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 142 | 85 | $3.41 | $484 |
| 82044 Clinical Chemistry | 35 | 32 | $6.11 | $214 |
| 87804 Immunoassay | 19 | 13 | $15.37 | $292 |
| 82270 Immunoassay | 14 | 14 | $4.29 | $60.06 |
Medicare prescription drug claims, 2024
In 2024, the drug April M Mahrle-Henson prescribed most often to Medicare patients was Rosuvastatin Calcium, with 587 prescriptions and refills. In total April M Mahrle-Henson wrote 6,301 Medicare prescriptions that cost $824K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 587 | 1,455 | 141 | $7,450 |
| Amlodipine Besylate Generic | 250 | 594 | 60 | $1,406 |
| Omeprazole Generic | 181 | 367 | 38 | $1,849 |
| Levothyroxine Sodium Generic | 170 | 450 | 44 | $2,065 |
| Furosemide Generic | 168 | 300 | 34 | $812 |
| Metformin Hcl Generic | 150 | 274 | 26 | $691 |
| Fluticasone Propionate Generic | 123 | 211 | 48 | $1,573 |
| Ramipril Generic | 118 | 282 | 31 | $1,984 |
| Tamsulosin Hcl Generic | 115 | 203 | 19 | $1,988 |
| Allopurinol Generic | 104 | 252 | 23 | $1,065 |
| Escitalopram Oxalate Generic | 98 | 168 | 13 | $670 |
| Sertraline Hcl Generic | 98 | 234 | 24 | $820 |
| Metoprolol Succinate Generic | 96 | 220 | 22 | $1,774 |
| Montelukast Sodium Generic | 93 | 165 | 14 | $772 |
| Losartan Potassium Generic | 92 | 232 | 22 | $717 |
Brand drugs: 936 claims; generic drugs: 5,346 claims; opioid claims: 187.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid April M Mahrle-Henson $1,599 ($1,599 in general payments such as food, travel and fees) from 21 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $237.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $237 |
| Lilly USA, LLC LLY | 10 | $189 |
| Amgen Inc. AMGN | 16 | $152 |
| Abbvie Inc. ABBV | 11 | $146 |
| Novo Nordisk Inc NVO | 7 | $143 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $102 |
| Radius Health, Inc. | 4 | $96.67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $82.71 |
| Pfizer Inc. PFE | 4 | $80.82 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $79.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.